1. 000165 PREDICTIVE VALUE OF FOCAL ADHESION KINASE IN CERVICAL CANCER STAGE I AND II: A CLINICO-PATHOLOGIC STUDY. (1st September 2005) Authors: Gabriel, B.; zur Hausen, A.; Dietz, C.; Klar, M.; Tempfer, C.; Gitsch, G.; Hasenburg, A. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 000243 EXTRAPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH CERVICAL CANCER. (1st September 2005) Authors: Hasenburg, A.; Denschlag, D.; Gabriel, G.; Mueller-Lantzsch, C.; Henne, K.; Gitsch, G. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 000333 THE EFFICACY OF TOPOTECAN IN RECURRENT OVARIAN CANCER. (1st September 2005) Authors: Kunze, M.; Hancke, K.; Hasenburg, A.; Gitsch, G.; Kaubitzsch, S. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ADENOVIRAL MEDIATED THYMIDINE KINASE GENE THERAPY FOR OVARIAN CANCER USING AN ESTROGENINDUCIBLE PROMOTER: A STEP TOWARDS TUMOR-SPECIFIC GENE THERAPY. Issue 1 (1st March 2003) Authors: Fischer, D.-C.; Hasenburg, A.; Delvoux, P.; Kieback, D. G. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COMBINED GENE- AND CHEMOTHERAPY FOR TREATMENT OF OVARIAN CANCER: IN-VITRO ANALYSIS OF COMBINED TREATMENT WITH A REPLICATION-DEFICIENT ADENOVIRAL VECTOR AND TOPOTECAN. Issue 1 (1st March 2003) Authors: Fischer, D.-C.; Becker, C.; Delvoux, P.; Hasenburg, A.; Kieback, D. G. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. (August 2018) Authors: Derks, M.G.M.; Bastiaannet, E.; van de Water, W.; de Glas, N.A.; Seynaeve, C.; Putter, H.; Nortier, J.W.R.; Rea, D.; Hasenburg, A.; Markopoulos, C.; Dirix, L.Y.; Portielje, J.E.A.; van de Velde, C.J.H.; Liefers, G.J. Journal: European journal of cancer Issue: Volume 99(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO. (October 2016) Authors: Klar, M.; Hasenburg, A.; Hasanov, M.; Hilpert, F.; Meier, W.; Pfisterer, J.; Pujade-Lauraine, E.; Herrstedt, J.; Reuss, A.; du Bois, A. Journal: European journal of cancer Issue: Volume 66(2016) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗